Login / Signup

PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A.

Maria Elisa MancusoTina BissKathelijn FischerMonika Maas EnriquezMacGregor SteeleMaria WangDespina Tseneklidou-StoeterSanjay AhujaGili Kenet
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)
BAY 94-9027 showed long-term safety and efficacy for the prevention and treatment of bleeds in younger and older paediatric patients with severe haemophilia A.
Keyphrases
  • early onset
  • emergency department
  • intensive care unit
  • young adults
  • physical activity
  • replacement therapy
  • drug induced
  • middle aged
  • water quality